A highly efficient virus sample preservation solution and its preparation method

Through a specific combination of virus sample preservation solution, the problem of nucleic acid release and degradation in the virus sample preservation solution is solved, and the long-term stability and safety of virus particles are achieved. It is suitable for long-term storage of room temperature, improving nucleic acid recovery and detection safety .

CN113621685BActive Publication Date: 2024-11-26HANTECH MEDICAL DEVICE CO
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202110784020.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-07-12
Publication Date
2024-11-26
Estimated Expiration
2041-07-12

AI Technical Summary

Technical Problem

The existing virus sample storage solution cannot effectively maintain the integrity of the virus particles, resulting in nucleic acid release, degradation and contamination, affecting the detection results, and the activity of conventional storage solution decreases rapidly, making it suitable for short-term storage.

Method used

High-efficiency virus sample storage solution including virus stabilizers, osmotic pressure stabilizers and cell membrane stabilizers is used to combine bacterial inhibitors to ensure the stability and safety of virus particles in the storage solution through specific component combinations and configuration methods.

Benefits of technology

Effectively maintain the integrity of virus particles, improve nucleic acid recovery rate, prolong virus activity, ensure detection safety, and reduce production difficulty and cost. It is suitable for long-term storage of room temperature.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The present invention discloses a highly efficient virus sample preservation solution and a method for preparing the same, including a virus stabilizer, an osmotic pressure stabilizer and a cell membrane stabilizer, wherein the virus stabilizer includes one or more of L-glutamine, L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, fat-soluble vitamins, water-soluble vitamins, and monosaccharides, and the osmotic pressure stabilizer includes one or more of sodium ions, potassium ions, magnesium ions, calcium ions, and phosphorus ions, and the cell membrane stabilizer is used to protect the integrity of virus particles, and the cell membrane stabilizer includes calcium ions and / or potassium ions. The present invention can maintain the integrity of virus particles to avoid the release, degradation, and contamination of nucleic acids, improve the recovery rate of nucleic acid collection, and the present invention is non-toxic, ensuring the safety of detection personnel, and the present invention optimizes the components, reduces the difficulty of production, and saves time and labor costs.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedical technology, and in particular to an efficient virus sample preservation solution and a preparation method thereof. Background Art

[0002] A virus is a small, simple-structured, non-cellular biological virus that consists of a long nucleic acid chain (DNA or RNA) and a protein shell. Viruses are widely distributed in nature and can infect humans, animals, plants, and bacteria. Since the concentration of the virus infects the host is low in the initial stage and the virus can multiply exponentially in the host, the virus is in the incubation period and the host does not show symptoms of infection. This allows some viruses to spread widely among the population, such as measles virus, influenza virus, SARS virus that broke out in 2003, ZIKV virus that was prevalent in 2015, and the new coronavirus that has spread globally in 2020. Identifying virus-specific nucleic acids is one of the methods for determining the species of the virus. Since the concentration of viruses in some environments is extremely low, it is usually necessary to use nucleic acid amplification technology to amplify the number of nucleic acids to facilitate subsequent qualitative or quantitative detection.

[0003] In clinical testing, improper preservation of virus samples can cause a variety of problems: the virus shell is easy to break, releasing nucleic acid. Since the sample contains a large amount of enzyme substances, it is easy to degrade and contaminate, resulting in missed pathogens and insufficient sensitivity leading to false negatives. The existing conventional virus preservation solution PBS is widely used in clinical practice, but the activity of the virus in it decreases very quickly, with a loss of activity of 35% within 12 hours, so it is only suitable for short-term preservation of the virus. The existing conventional ordinary preservation solution on the market cannot guarantee the stability of the sample without degradation. Therefore, it is particularly important to develop a preservation solution that maintains the integrity of the virus particles to avoid the release, degradation, and contamination of nucleic acids, ensure the safety of test personnel, and improve the recovery rate of collected nucleic acids. Summary of the invention

[0004] The purpose of the present invention is to solve the shortcomings existing in the prior art and to propose an efficient virus sample preservation solution and a preparation method thereof, which can maintain the integrity of virus particles to avoid the release, degradation and contamination of nucleic acids, improve the recovery rate of collected nucleic acids, and the present invention is non-toxic, ensuring the safety of detection personnel. The present invention optimizes the components, reduces the difficulty of production, and saves time and labor costs.

[0005] To achieve the above object, the present invention provides the following technical solutions:

[0006] The present invention provides a highly efficient virus sample preservation solution, comprising a virus stabilizer, an osmotic pressure stabilizer and a cell membrane stabilizer, wherein the virus stabilizer comprises one or more of L-glutamine, L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, fat-soluble vitamins, water-soluble vitamins and monosaccharides, the osmotic pressure stabilizer comprises one or more of sodium ions, potassium ions, magnesium ions, calcium ions and phosphorus ions, the cell membrane stabilizer is used to protect the integrity of virus particles, and the cell membrane stabilizer comprises calcium ions and / or potassium ions.

[0007] Furthermore, the virus sample preservation solution also includes an antibacterial agent, which is an antibiotic, and the concentration of the antibacterial agent is 0.01% to 10%.

[0008] Furthermore, the virus stabilizer contains the following ingredients per liter of the preservation solution: 270mg~310mg L-arginine, 40mg~60mg L-asparagine, 10mg~30mg L-aspartic acid, 55mg~75mg L-cysteine ​​dihydrochloride, 10mg~30mg L-glutamic acid, 5mg~15mg glycine, 10mg~20mg L-histidine, 10mg~30mg L-hydroxyproline, 40mg~60mg L-isoleucine, 40mg~60mg L-leucine, 30mg~50mg L-lysine hydrochloride, 10mg~20mg L-methionine, 10mg~20mg L-phenylalanine, 10mg~30mg L-proline, 20mg~40mg L-serine, 280mg~320mg L-glutamine, and 1g~3g glucose.

[0009] Furthermore, the osmotic pressure stabilizer in each liter of the preservation solution contains the following ingredients: 1.38g to 3.38g of 4-hydroxyethylpiperazineethanesulfonic acid, 47.84mg to 49.84mg of anhydrous magnesium sulfate, and 656.13mg to 696.13mg of anhydrous sodium dihydrogen phosphate.

[0010] Furthermore, the cell membrane stabilizer in each liter of the preservation solution contains the following ingredients: 80 mg to 120 mg of calcium nitrate.

[0011] Furthermore, the antibacterial agent in each liter of the preservation solution contains the following components: 10ml to 20ml of penicillin / streptomycin dual antibiotics.

[0012] Furthermore, the pH value of the virus sample preservation solution is 6.5-7.5.

[0013] The present invention also provides an efficient method for preparing a virus sample preservation solution, taking the preparation of 1L of virus sample preservation solution as an example, comprising the following steps:

[0014] S1. Weigh the above-mentioned virus stabilizer, osmotic pressure stabilizer, cell stabilizer and antibacterial agent into a beaker and mix well.

[0015] S2, add 700ml purified water;

[0016] S3. Stir gently until the raw materials are completely dissolved;

[0017] S4. Slowly add 1 mol / L NaOH solution and stir evenly to make the pH value of the virus sample preservation solution reach 6.5-7.5;

[0018] S5. Add purified water to make up to 1 L.

[0019] Compared with the prior art, the beneficial effects of the present invention are as follows: the present preservation solution is based on the same-layer plasma technology, and a variety of proprietary ingredients such as specific virus activity stabilizers, osmotic pressure stabilizers, cell membrane stabilizers, antibacterial agents, etc. are organically combined to develop a virus preservation product with stable performance. Virus particles are preserved in the present preservation solution for a period of time without breaking, maintaining biological activity, thereby ensuring the nucleic acid content and not affecting downstream detection; the present solution is non-toxic, reducing hazards to operators; secondly, the present invention optimizes the components, reduces the difficulty of production, saves time and labor costs; the raw material preparation processes in the formula are mature and easy to purchase. The present preservation solution can be stored at room temperature for more than half a year, reducing the cost of cold chain transportation and having higher market applicability. DETAILED DESCRIPTION

[0020] The present invention will be described in more detail below. It should be noted that the following description of the present invention is only illustrative and not restrictive. The various embodiments can be combined with each other to form other embodiments not shown in the following description.

[0021] In the description of the present invention, it should be noted that directional words, such as the terms "center", "lateral", "longitudinal", "length", "width", "thickness", "up", "down", "front", "back", "left", "right", "vertical", "horizontal", "top", "bottom", "inside", "outside", "clockwise", "counterclockwise", etc., indicating directions and positional relationships are only for the convenience of describing the present invention and simplifying the description, and do not indicate or imply that the referred device or element must have a specific orientation, be constructed and operated in a specific orientation, and cannot be understood as limiting the specific scope of protection of the present invention.

[0022] In addition, the terms "first" and "second" are used for descriptive purposes only and cannot be understood as indicating or implying relative importance or implicitly indicating the number of technical features. Therefore, the definition of "first" and "second" features can explicitly or implicitly include one or more of the features. In the description of the present invention, the meaning of "several" is two or more, unless otherwise clearly and specifically defined.

[0023] In the present invention, unless otherwise specified and limited, the terms "assemble", "connect", and "connection" should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral connection; it can also be a mechanical connection; it can be directly connected, or it can be connected through an intermediate medium, or the two elements can be internally connected. For those of ordinary skill in the art, the specific meanings of the above terms in the present invention can be understood according to specific circumstances.

[0024] A highly efficient virus sample preservation solution comprises a virus stabilizer, an osmotic pressure stabilizer and a cell membrane stabilizer. The virus stabilizer comprises one or more of L-glutamine, L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, fat-soluble vitamins, water-soluble vitamins and monosaccharides. Among them, glucose is generally used as a monosaccharide. In addition to being a virus activity stabilizer, it also provides a carbon source and provides the virus with the nutrients it needs for survival. The osmotic pressure stabilizer is to provide an isotonic environment for the virus, and comprises one or more of sodium ions, potassium ions, magnesium ions, calcium ions and phosphorus ions. Na+ plays a key role in maintaining the constant osmotic pressure, K+ is of great significance in regulating the preservation solution environment, and Mg2+ and phosphorus ions are of great significance in maintaining virus stability. The cell membrane stabilizer is used to protect the integrity of virus particles, and the cell membrane stabilizer comprises calcium ions and / or potassium ions.

[0025] The preservation solution should provide a non-toxic and pollution-free environment, so the virus sample preservation solution also includes an antibacterial agent, which is an antibiotic that not only maintains the activity of the virus but also effectively inhibits the growth of bacteria. The concentration of the antibacterial agent is 0.01% to 10%.

[0026] The virus stabilizer contains the following ingredients per liter of preservation solution: L-arginine 270mg~310mg, L-asparagine 40mg~60mg, L-aspartic acid 10mg~30mg, L-cystine dihydrochloride 55mg~75mg, L-glutamic acid 10mg~30mg, glycine 5mg~15mg, L-histidine 10mg~20mg, L-hydroxyproline 10mg~30mg, L-isoleucine 40mg~60mg, L-leucine 40mg~60mg, L-lysine hydrochloride 30mg~50mg, L-methionine 10mg~20mg, L-phenylalanine 10mg~20mg, L-proline 10mg~30mg, L-serine 20mg~40mg, L-glutamine 280mg~320mg, glucose 1g~3g. These amino acids can form a protective film on the protein shell of the virus, making it difficult to break down and ensuring the integrity of the virus.

[0027] The osmotic pressure stabilizer in each liter of preservation solution contains the following ingredients: 1.38g to 3.38g of 4-hydroxyethylpiperazineethanesulfonic acid, 47.84mg to 49.84mg of anhydrous magnesium sulfate, and 656.13mg to 696.13mg of anhydrous sodium dihydrogen phosphate.

[0028] The cell membrane stabilizer contains the following ingredients per liter of preservation solution: 80 mg to 120 mg of calcium nitrate.

[0029] The antibacterial agent in each liter of storage solution contains the following ingredients: 10ml to 20ml of penicillin / streptomycin dual antibiotics. Penicillin / streptomycin dual antibiotics as antibacterial agents do not affect downstream fluorescence quantitative PCR detection. Traditional antibacterial agents such as imidazolidinyl urea and sorbic acid will affect downstream fluorescence quantitative PCR detection after addition.

[0030] The isotonic environment requires the pH to be stable within a certain range. The pH value of this virus sample preservation solution is 6.5-7.5.

[0031] An efficient method for preparing virus sample preservation solution, taking the preparation of 1L virus sample preservation solution as an example, comprises the following steps:

[0032] S1. Weigh the above-mentioned virus stabilizer, osmotic pressure stabilizer, cell stabilizer and antibacterial agent into a beaker and mix well.

[0033] S2, add 700ml purified water;

[0034] S3. Gently stir until the raw materials are completely dissolved. There is no need to heat the culture medium during this process.

[0035] S4. Slowly add 1 mol / L NaOH solution and stir evenly to make the pH value of the virus sample preservation solution reach 6.5-7.5;

[0036] S5. Add purified water to make up to 1 L.

[0037] The virus sample preservation solution prepared in the present invention was subjected to the following experiments:

[0038] Preservative solution validity test

[0039] Using influenza virus identified in the hospital as specimen, test whether the Ct value of the sample is within the normal reference value range (18.00-36.00).

[0040] 1. Take 45 tubes of preservation solution from two batches and store them under different conditions. The sample distribution is as follows:

[0041] batch Quantity (pcs) serial number Storage temperature(℃) 1 15 #1 -20 2 15 #2 -20 1 15 #3 Laboratory normal temperature 2 15 #4 Laboratory normal temperature 1 15 #5 30-35 2 15 #6 30-35

[0042] Among them, the virus dilution gradient was 1:100;

[0043] 2. Take one sample from each of the above six groups of samples each month, dilute and store the sample for 24 hours before performing fluorescence quantitative PCR. This process lasted for 12 months. The test results are as follows:

[0044]

[0045]

[0046] It can be seen that the present invention can be preserved for a long time under various environments.

[0047] Comparative experiment on virus preservation and amplification efficiency

[0048] The novel coronavirus was used as the test sample to detect the Ct value of the ORF gene amplification. Three groups of virus sample preservation solutions of the present invention and three groups of virus sample preservation solutions sold on the market were used for experiments. The experimental results are as follows:

[0049]

[0050]

[0051] According to the above data, in the first 24 hours, there was no significant difference in preservation performance between this preservation solution and the comparison preservation solution. However, the 48-hour and 72-hour data showed that the Ct of this preservation solution was stable, but the comparison preservation solution changed greatly, indicating that the comparison preservation solution was not effective in long-term preservation of virus samples.

[0052] It will be apparent to those skilled in the art that the present invention is not limited to the details of the exemplary embodiments described above and that the present invention can be implemented in other specific forms without departing from the spirit or essential features of the present invention. Therefore, the embodiments should be considered exemplary and non-restrictive in all respects, and the scope of the present invention is defined by the appended claims rather than the above description, and it is intended that all changes falling within the meaning and scope of the equivalent elements of the claims be included in the present invention.

Claims

1. An efficient virus sample preservation solution, characterized in that: The invention comprises a virus stabilizer, an osmotic pressure stabilizer and a cell membrane stabilizer. The virus stabilizer in each liter of the preservation solution contains the following ingredients: 270mg-310mg L-arginine, 40mg-60mg L-asparagine, 10mg-30mg L-aspartic acid, 55mg-75mg L-cystine dihydrochloride, 10mg-30mg L-glutamic acid, 5mg-15mg glycine, 10mg-20mg L-histidine, 10mg-30mg L-hydroxyproline, 40mg-60mg L-isoleucine, 40mg-60mg L-leucine, 30mg-50mg L-lysine hydrochloride, 10mg-20mg L-methionine, 10mg-20mg L-phenylalanine, 10mg-20mg L-proline, 20mg-40mg L-serine 0mg, L-glutamine 280mg~320mg, glucose 1g~3g, the osmotic pressure stabilizer in each liter of the preservation solution contains the following ingredients: 4-hydroxyethylpiperazineethanesulfonic acid 1.38g~3.38g, anhydrous magnesium sulfate 47.84mg~49.84mg, anhydrous sodium dihydrogen phosphate 656.13mg~696.13mg, the cell membrane stabilizer is used to protect the integrity of virus particles, and the cell membrane stabilizer includes calcium ions and / or potassium ions; the virus sample preservation solution also includes an antibacterial agent, which is an antibiotic, and the concentration of the antibacterial agent is 0.01%~10%; the antibacterial agent in each liter of the preservation solution contains the following ingredients: penicillin / streptomycin double antibiotic 10ml~20ml; the cell membrane stabilizer in each liter of the preservation solution contains the following ingredients: calcium nitrate 80mg~120mg.

2. The highly efficient virus sample preservation solution according to claim 1, characterized in that: The pH value of the virus sample preservation solution is 6.5-7.

5.

3. An efficient method for preparing a virus sample preservation solution, characterized in that: Taking the preparation of 1L virus sample preservation solution as an example, the following steps are included: S1. Weigh the virus stabilizer, osmotic pressure stabilizer, cell stabilizer and antibacterial agent as described in claim 1 into a beaker and mix them evenly; S2, add 700ml purified water; S3. Stir gently until the raw materials are completely dissolved; S4. Slowly add 1 mol / L NaOH solution and stir evenly to make the pH value of the virus sample preservation solution reach 6.5-7.5; S5. Add purified water to make up to 1 L.